Urothelial cell intracytoplasmic inclusions after treatment of promyelocytic leukemia with arsenic trioxide

Toxicological Sciences

Volumn 134, Issue 2, 2013, Pages 271-275

  Wedel, Whitney R ^a   Muirhead, David E ^a   Arnold, Lora L ^a   Dodmane, Puttappa R ^a   Lele, Subodh M ^a   Maness Harris, Lori ^a,b   Hoyt, Rose ^a,b   Cohen, Samuel M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Arsenic trioxide; Bladder; Urothelial cell

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID;

ADULT; ARTICLE; CASE REPORT; CELL INCLUSION; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; MALE; MICRONUCLEUS; MICROSCOPY; PROMYELOCYTIC LEUKEMIA; SIDE EFFECT; URINALYSIS; UROTHELIUM;

ARSENIC TRIOXIDE; BLADDER.; UROTHELIAL CELL;

ADULT; AGED; ARSENICALS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; OXIDES; UROTHELIUM;

EID: 84880690153     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft120     Document Type: Article

References (18)

1. Brown, A. C., Bullock, C. G., Gilmore, R. S., Wallace, W. F., and Watt, M. (1985). Mitochondrial granules: Are they reliable markers for heavy metal cations? J. Anat. 140(Pt 4), 659-667.
2. Chen, G. Q., Shi, X. G., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z. G., Ni, J. H., Shi, G. Y., Jia, P. M., et al. (1997). Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dosedependent dual effects on APL cells. Blood 89, 3345-3353.
3. Ghosh, P., Basu, A., Singh, K. K., and Giri, A. K. (2008) Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population. Mol. Cancer 7. doi:10.1186/1476-4598-7-45.
4. Gonick, H. C. 2011. Lead-binding proteins: A review. J. Toxicol. Article Id: 686050. doi: 10.1155/2011/686050 2011;2011:686050.
5. Hernández-Zavala, A., Valenzuela, O. L., Matoušek, T., Drobná, Z., Dedina, J., Garcia-Vargasw, G. G., Thomas, D. J., Del Razo, L. M., and Stýblo, M. (2008) Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water. Environ. Health Perspect. 116, 1656-1660.
6. Kwong, Y. L., and Todd, D. (1997). Delicious poison: Arsenic trioxide for the treatment of leukemia [letter]. Blood 89, 3487-3488.
7. Marchiset-Ferlay, N., Savanovitch, C., and Sauvant-Rochat, M. P. (2012). What is the best biomarker to assess arsenic exposure via drinking water? Environ. Int. 39, 150-171.
8. Masci, O., and Bongarzone, R. (1995). General toxicity. In Inorganic Lead Exposure. Metabolism and Intoxication (N. Castellino, P. Castellino, and N. Sannolo, Eds.), pp. 211-213. CRC Press, Inc., Boca Raton, FL.
9. Moore, L. E., Smith, A. H., Hopenhayn-Rich, C., Biggs, M. L., Kalman, D. A., and Smith, M. T. (1997). Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol. Biomarkers Prev. 6, 31-36.
10. National Research Council Subcommittee on Arsenic in Drinking Water. (1999). Arsenic in Drinking Water. National Academy Press, Washington, DC.
11. National Research Council Subcommittee on Arsenic in Drinking Water. (2001). Arsenic in Drinking Water. 2001 Update. National Academy Press, Washington, DC.
12. Nersesyan, A., Kundi, M., Atefie, K., Schulte-Hermann, R., and Knasmuller, S. (2006). Effect of staining procedures on the results of micronucleus assays with exfoliated oral mucosa cells. Cancer Epidemiol. Biomarkers Prev. 15, 1835-1840.
13. Rebel, J. M., de Boer, W. I., Thijssen, C. D., Vermey, M., Zwarhoff, E. C., and Van der Kwast, T. H. (1994). An in vitro model of urothelial regeneration: Effects of growth factors and extracellular matrix proteins. J. Pathol. 173, 283-291.
14. Shen, Z. X., Chen, G. Q., Ni, J. H., Li, X. S., Xiong, S. M., Qiu, Q. Y., Zhu, J., Tang, W., Sun, G. L., Yang, K. Q., et al. (1997). Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89, 3354-3360.
15. Smith, A. H., Hopenhayn-Rich, C., Bates M. N., Goeden, H. M., Hertz-Picciotto, I., Duggan, H. M., Wood, R., Kosnett, M. J., and Smith, M. T. (1992). Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97, 259-267.
16. Suzuki, S., Arnold, L. L., Muirhead, D., Lu, X., Le, X. C., Bjork, J. A., Wallace, K. B., Ohnishi, T., Kakiuchi-Kiyots, S., Pennington, K. L., et al. (2008) Inorganic arsenic-induced intramitochondrial granules in mouse urothelium. Toxicol. Pathol. 36, 999-1005.
17. Tiltman, A. J., and Friedell, G. H. (1972). Effect of feeding N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide on mitotic activity of rat urinary-bladder epithelium. J. Natl. Cancer Inst. 48, 125-129.
18. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. (1989). Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130, 1123-1132.